Financial Performance Expectations - The company expects a net profit attributable to shareholders of between 24.8 million and 29.8 million yuan, representing a year-on-year increase of 41.60% to 70.15%[3] - The net profit after deducting non-recurring gains and losses is projected to be between 23.03 million and 31.17 million yuan, reflecting a year-on-year growth of 46.24% to 97.93%[3] Factors Contributing to Performance Increase - The increase in performance is attributed to a recovery in downstream market demand and efforts in market expansion, technological innovation, and product application development[5]

证券代码：301209 证券简称：联合化学 公告编号：2024-017 龙口联合化学股份有限公司 2023年年度权益分派实施公告 公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 3、 本次实施的分配方案与2023年年度股东大会审议的分配方案一致。 4、 本次分配方案的实施距离股东大会审议通过的时间未超过两个月。 二、权益分派方案 公司2023年年度权益分派方案为：以公司现有总股本80,000,000股为基数， 向全体股东每10股派1.20元人民币现金（含税；扣税后，QFII、RQFII以及持有 首发前限售股的个人和证券投资基金每10股派1.08元；持有首发后限售股、股权 激励限售股及无限售流通股的个人股息红利税实行差别化税率征收，公司暂不扣 缴个人所得税，待个人转让股票时，根据其持股期限计算应纳税额【注】；持有 首发后限售股、股权激励限售股及无限售流通股的证券投资基金所涉红利税，对 1 龙口联合化学股份有限公司（以下简称"公司"），2023年年度权益分派方 案已获2024年5月17日召开的2023年年度股东大会审议通过，现将权益分派事宜 公告如下： 一、 股东 ...

证券代码：301209 证券简称：联合化学 公告编号：2024-016 龙口联合化学股份有限公司 2023 年年度股东大会决议公告 公司及董事会全体成员保证信息披露内容的真实、准确和完整，没 有虚假记载、误导性陈述或者重大遗漏。 3、本次股东大会以现场投票与网络投票相结合的方式召开； 4、为尊重中小投资者利益，提高中小投资者对公司股东大会决议事项的参 与度，本次股东大会对中小投资者进行单独计票，中小投资者是指除上市公司董 事、监事、高级管理人员以及单独或者合计持有公司5%以上股份的股东以外的其 他股东。 一、会议召开和出席情况 （一） 股东大会届次：2023年年度股东大会。 1、现场会议时间：2024年5月17日（星期五）下午14:30。 2、网络投票起止时间：通过深圳证券交易所交易系统进行网络投票的具体 时间：2024年5月17日上午9:15-9:25、9:30-11:30，下午13:00-15:00；通过深 圳证券交易所互联网投票系统投票的具体时间为：2024年5月17日9:15至15:00 期间的任意时间。 现场会议召开地点：山东省烟台市龙口市龙口联合化学股份有限公司二楼会 议室。 （五）会议召开方式： ...

北京植德律师事务所 植德京(会)字[2024]0061 号 致：龙口联合化学股份有限公司（贵公司） 北京植德律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出 席并见证贵公司 2023 年年度股东大会（以下简称"本次会议"）。 本所律师参加本次会议进行见证，并根据《中华人民共和国公司法》（以下 简称《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）、《上 市公司股东大会规则》（以下简称《股东大会规则》）、《律师事务所从事证券 法律业务管理办法》（以下简称《证券法律业务管理办法》）、《律师事务所证 券法律业务执业规则（试行）》（以下简称《证券法律业务执业规则》）等相关 法律、行政法规、规章、规范性文件及《龙口联合化学股份有限公司章程》（以 下简称《公司章程》）的规定，就本次会议的召集与召开程序、召集人资格、出 席会议人员资格、会议表决程序及表决结果等事宜，出具本法律意见书。 对本法律意见书的出具，本所律师特作如下声明： 1．本所律师仅就本次会议的召集与召开程序、召集人和出席现场会议人员 资格、会议表决程序及表决结果的合法性发表意见，不对本次会议所审议的议案 内容及该等议案所表述的事实或数据的真 ...

证券代码：301209 证券简称：联合化学 公告编号：2024-015 龙口联合化学股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、 股票交易异常波动的具体情况 龙口联合化学股份有限公司（以下简称"公司"）股票交易连续三个交易日 内（2024年4月30日、2024年5月6日、2024年5月7日）日收盘价涨幅偏离值累计超 过30%，根据《深圳证券交易所交易规则》的有关规定，属于股票交易异常波动的 情形。 二、 对重要问题的关注、核实情况说明 针对公司股票交易异常波动，公司董事会对公司、控股股东及实际控制人就 有关事项进行了核查，相关情况说明如下： 1、 公司前期所披露的信息，不存在需要更正、补充之处； 2、 公司未发现近期公共媒体报道了可能或者已经对本公司股票交易价格产 生较大影响的未公开重大信息； 4、 经核查，公司控股股东、实际控制人及一致行动人在股票交易异常波动 期间不存在买卖公司股票的情形； 5、 公司不存在违反公平信息披露的情形。 三、 关于不存在应披露而未披露信息的说明 本公司董事会确认，本公司目前没有任何根据 ...

Financial Performance - The company's revenue for Q1 2024 was ¥129,385,035.56, representing a 26.83% increase compared to ¥102,012,228.80 in the same period last year[5] - Net profit attributable to shareholders was ¥14,022,784.51, up 46.99% from ¥9,540,054.26 year-on-year[5] - The total profit for Q1 2024 was ¥16,328,947.58, a 54.68% increase from ¥10,556,882.14 in the same quarter last year[8] - Operating profit for Q1 2024 was ¥16,574,602.57, up 54.0% from ¥10,728,019.80 in the same period last year[19] - Net profit attributable to the parent company was ¥14,022,784.51, representing a 46.5% increase from ¥9,540,054.26 in Q1 2023[19] - Basic and diluted earnings per share increased by 46.94% to ¥0.1753 from ¥0.1193 in the previous year[5] - Basic and diluted earnings per share for Q1 2024 were both ¥0.1753, compared to ¥0.1193 in Q1 2023, reflecting a 47.0% increase[19] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 84.55%, amounting to ¥2,996,038.33 compared to ¥19,397,759.48 in Q1 2023[5] - The net increase in cash and cash equivalents was ¥2,603,936.67, down 93.30% from ¥38,863,475.04 in Q1 2023[9] - Cash flow from operating activities generated a net amount of ¥2,996,038.33, a significant decrease of 84.6% from ¥19,397,759.48 in Q1 2023[21] - The company reported a cash and cash equivalents balance of ¥384,126,213.91 at the end of Q1 2024, up from ¥366,696,430.78 at the end of Q1 2023[22] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥829,064,327.70, a 2.29% increase from ¥810,539,193.07 at the end of the previous year[5] - The company's total assets as of March 31, 2024, amount to 829,064,327.70 RMB, an increase from 810,539,193.07 RMB at the beginning of the period[13] - The total current assets are reported at 711,340,652.66 RMB, compared to 688,933,886.82 RMB at the beginning of the period, reflecting a growth of approximately 3.4%[13] - The total liabilities amount to 126,474,761.12 RMB, up from 122,614,406.68 RMB, indicating an increase of about 3.0%[15] - Total liabilities and equity amounted to ¥829,064,327.70, reflecting a 2.3% increase from ¥810,539,193.07 in the previous year[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,094[10] - The largest shareholder, Longkou Sunshine Chemical Co., Ltd., holds 42.83% of shares, totaling 34,260,000 shares[10] Research and Development - Research and development expenses rose by 34.30% to ¥5,669,841.74, reflecting the company's increased investment in R&D[8] - Research and development expenses rose to ¥5,669,841.74, up 34.4% from ¥4,221,623.72 in the previous year[17] Sales and Marketing - The company's sales expenses surged by 162.04% to ¥1,267,953.72, primarily due to increased sales revenue[8] Inventory and Receivables - The accounts receivable increased to 95,507,135.61 RMB from 76,222,556.03 RMB, showing a growth of approximately 25.3%[13] - The inventory level rose to 111,895,059.82 RMB, compared to 102,511,467.92 RMB, marking an increase of about 9.3%[13] Other Information - The company received government subsidies amounting to ¥1,029,992.92, which was a 51.42% decrease compared to the previous year[8] - The company has no preferred shareholders or any changes in restricted shares during the reporting period[12] - The company did not report any new product launches or significant market expansion strategies during this quarter[23]

龙口联合化学股份有限公司 审计报告 和信审字（2024）第 000190 号 | 目 录 | 页 码 | | --- | --- | | 一、审计报告 | 1-5 | | 二、已审财务报表及附注 | | | 1、资产负债表 | 6-7 | | 2、利润表 | 8 | | 3、现金流量表 | 9 | | 4、股东权益变动表 | 10-11 | | 5、财务报表附注 | 12-81 | 和信会计师事务所（特殊普通合伙） 二○二四年四月二十六日 龙口联合化学股份有限公司 2023 年度审计报告 审 计 报 告 和信审字(2024)第 000190 号 龙口联合化学股份有限公司全体股东： 一、审计意见 我们审计了龙口联合化学股份有限公司（以下简称联合化学公司）财务报表， 包括 2023 年 12 月 31 日的资产负债表，2023 年度的利润表、现金流量表、股东权 益变动表以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制， 公允反映了联合化学公司 2023 年 12 月 31 日的财务状况以及 2023 年度的经营成 果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计 ...

龙口联合化学股份有限公司 2023 年度监事会工作报告 各位股东： 龙口联合股份有限公司（以下简称"公司"）监事会由 3 名监事组成，监事 会严格按照《公司法》《公司章程》《监事会议事规则》等有关规定和要求，认真 履行和独立行使监事会的监督职权和职责。2023 年公司共召开 6 次监事会，监 事会成员列席了 2023 年内的股东大会，对公司经营活动、财务状况、重大决策、 股东大会召开程序以及董事、高级管理人员履行职责情况等方面实施了有效监督， 保障了公司股东权益、公司利益和员工的合法权益，促进了公司的规范运作。 一、监事会 2023 年度工作情况 2023 年监事会召开情况如下： | 会议时间 | 会议届次 | 审议议案 | | --- | --- | --- | | | | 1.《关于公司<2022 年年度报告>全文及其摘要的 | | | | 议案》 | | | | 2.《关于续聘和信会计师事务所（特殊普通合伙） | | | | 为 2023 年度审计机构的议案》 | | | | 3.《关于公司 2022 年度财务决算报告的议案》 | | | | 4.《关于公司 2023 年度财务预算报告的议案》 | | ...

中德证券有限责任公司 关于龙口联合化学股份有限公司 2023 年度募集资金存放与使用情况的核查意见 中德证券有限责任公司（以下简称"中德证券"或"保荐机构"）作为龙口联合 化学股份有限公司（以下简称"联合化学"或"公司"）首次公开发行股票并在创业 板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司监管指 引第 2 号——上市公司募集资金管理和使用的监管要求》《深圳证券交易所创业 板股票上市规则》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业 务》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运 作》等有关规定，对联合化学 2023 年度募集资金的存放与使用情况进行了审慎 核查，核查情况如下： 一、募集资金基本情况 实际募集资金金额，资金到账时间 经中国证券监督管理委员会《关于同意龙口联合化学股份有限公司首次公开 发行股票注册的批复》（证监许可〔2022〕1176 号）同意注册，并经深圳证券交 易所同意，公司首次公开发行人民币普通股（A 股）2,000 万股，每股发行价为 人民币 14.95 元，募集资金总额 29,900.00 万元，扣除相关发行费用 4,068 ...

Financial Performance - The company's operating revenue for 2023 was ¥428,388,426.10, a decrease of 20.96% compared to ¥541,984,420.48 in 2022[18]. - The net profit attributable to shareholders for 2023 was ¥33,829,831.37, down 47.27% from ¥64,154,917.71 in 2022[18]. - The basic earnings per share for 2023 was ¥0.4229, reflecting a decline of 56.05% from ¥0.9623 in 2022[18]. - The total assets at the end of 2023 amounted to ¥810,539,193.07, representing a 3.38% increase from ¥784,022,630.65 at the end of 2022[18]. - The net assets attributable to shareholders at the end of 2023 were ¥687,924,786.39, an increase of 2.96% from ¥668,170,163.62 at the end of 2022[18]. - The cash flow from operating activities for 2023 was ¥69,684,762.23, a slight decrease of 1.93% compared to ¥71,056,614.54 in 2022[18]. - The company reported a total of ¥2,185,185.98 in non-recurring gains and losses for 2023, significantly lower than ¥11,443,975.75 in 2022[24]. - The company achieved operating revenue of CNY 428.39 million, a decrease of 20.96% year-on-year, and a net profit attributable to shareholders of CNY 33.83 million, down 47.27% year-on-year[61]. - The chemical segment contributed CNY 427.47 million, accounting for 99.79% of total revenue, with a year-on-year decline of 21.12%[63]. - The pigment product line generated CNY 408.29 million, representing 95.31% of total revenue, with a decrease of 21.22% compared to the previous year[63]. Dividend Distribution - The company plans to distribute a cash dividend of 1.20 RMB per 10 shares to all shareholders, based on a total of 80,000,000 shares[3]. - The total distributable profit for the year is RMB 150,593,523.96, indicating a strong profitability position[172]. - The company has not issued any bonus shares or capital reserve transfers during this distribution[172]. Corporate Governance - The company has established a comprehensive governance structure, including a shareholders' meeting, board of directors, and supervisory board, ensuring effective management and oversight[175]. - The board of directors convened 5 meetings, with full attendance from all directors, ensuring compliance with governance regulations[117]. - The supervisory board held 6 meetings, with all supervisors present, adhering to the company's governance structure[118]. - The audit committee conducted 6 meetings during the reporting period, maintaining regular oversight of financial practices[122]. - The company has a dedicated human resources department, ensuring independent management of employee affairs[129]. - The company maintains a separate financial accounting department, allowing for independent financial decision-making[130]. - The company has implemented a "Quality Return Double Improvement" action plan, although details on its execution were not disclosed[113]. - The company is committed to maintaining compliance with corporate governance standards and enhancing its operational efficiency[151]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and development strategies, indicating potential risks in its operations[3]. - The company has identified risks related to environmental compliance, safety production, and reliance on DIC Corporation, which significantly impacts its revenue and cash flow[105][107][109]. - The company is facing intensified competition in the organic pigment industry, with supply exceeding demand, necessitating continuous innovation in technology and management[110]. Research and Development - The R&D team consists of over 60 members, holding 11 invention patents and 14 utility model patents, with a focus on developing high-performance and environmentally friendly products[55]. - The company has developed over 200 customized pigment products and holds 11 invention patents and 14 utility model patents, enhancing its R&D capabilities[98]. - The company completed several R&D projects aimed at developing environmentally friendly organic pigments for various applications, enhancing product competitiveness[72]. - The company plans to enhance its R&D efforts to develop more high-performance eco-friendly pigment products, with a focus on azo organic pigments for the ink industry[100]. Environmental Compliance - The company has complied with environmental regulations and holds a valid pollutant discharge permit issued by the local environmental authority[192]. - The company has managed hazardous waste disposal through contracts with qualified disposal units, ensuring compliance with relevant regulations[193]. - The company has implemented measures to manage pollutant emissions effectively, adhering to industry standards[192]. - The company has invested a total of 4.55 million yuan in environmental protection during the reporting period, covering water treatment materials, hazardous waste disposal, and the construction of environmental facilities[199]. - The company has established a wastewater treatment station that meets discharge standards, utilizing caustic soda to adjust pH and liquid oxygen to reduce color[195]. Market Position and Strategy - The company operates in the organic pigment industry, which has seen expanding applications in various sectors, including automotive and construction[28]. - The company is positioned as a major player in the organic pigment industry, benefiting from China's status as a leading production and consumption market for fine chemicals[48]. - The company plans to leverage e-commerce and international exhibitions to expand its overseas market presence, including new markets in South America and ASEAN[103]. - The company aims to achieve full automation in production processes, with the first phase already completed for liquid raw material handling and reaction conditions[102]. Employee Management - The total number of employees at the end of the reporting period is 378, with 266 in production, 10 in sales, 66 in technical roles, 7 in finance, and 29 in administration[167]. - The company provides competitive salaries and benefits, including pension, medical, work injury, unemployment insurance, and housing fund contributions[169]. - The company emphasizes employee training and development, implementing an annual training plan that includes both internal and external training methods[170]. Management Changes - The company experienced a change in management, with Li Xiumei resigning as General Manager on August 17, 2023, while remaining as Chairwoman[138]. - Ma Chengzhi was appointed as the new General Manager on August 17, 2023, following the resignation of Li Xiumei[138]. - The company’s supervisory board elected Liu Desheng as the new Chairman of the Supervisory Board on June 28, 2023[137]. Financial Management - The company has not reported any penalties from regulatory authorities for its directors, supervisors, or senior management in the past three years[150]. - The company has established a remuneration decision-making process that aligns with its articles of association and relevant regulations[151]. - The total pre-tax remuneration for the board of directors, supervisors, and senior management amounted to 307.02 million CNY[156].